These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1798679)

  • 1. 14C-isomazole disposition in man after oral administration.
    Woodworth JR; DeLong AF; Fasola AF; Oldham S
    Pharm Res; 1991 Nov; 8(11):1413-7. PubMed ID: 1798679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isomazole disposition in man as a function of dose and route of administration.
    Woodworth JR; Delong AF; Fasola AF; Oldham S
    Biopharm Drug Dispos; 1991 Dec; 12(9):673-86. PubMed ID: 1790312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition and metabolism of [14C]fluconazole in humans.
    Brammer KW; Coakley AJ; Jezequel SG; Tarbit MH
    Drug Metab Dispos; 1991; 19(4):764-7. PubMed ID: 1680653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.
    De Bie AT; Van Ommen B; Bär A
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):150-8. PubMed ID: 9671569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans.
    Carlin JR; Höglund P; Eriksson LO; Christofalo P; Gregoire SL; Taylor AM; Andersson KE
    Drug Metab Dispos; 1992; 20(2):148-55. PubMed ID: 1352203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of vigabatrin following a single oral dose of [14C]vigabatrin in healthy male volunteers.
    Durham SL; Hoke JF; Chen TM
    Drug Metab Dispos; 1993; 21(3):480-4. PubMed ID: 8100505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass balance study of [14C] rabeprazole following oral administration in healthy subjects.
    Setoyama T; Drijfhout WJ; van de Merbel NC; Humphries TJ; Hasegawa J
    Int J Clin Pharmacol Ther; 2006 Nov; 44(11):557-65. PubMed ID: 17176622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of 14C-rifapentine in healthy volunteers.
    Reith K; Keung A; Toren PC; Cheng L; Eller MG; Weir SJ
    Drug Metab Dispos; 1998 Aug; 26(8):732-8. PubMed ID: 9698286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mass balance study to evaluate the biotransformation and excretion of [14C]-triamcinolone acetonide following oral administration.
    Argenti D; Jensen BK; Hensel R; Bordeaux K; Schleimer R; Bickel C; Heald D
    J Clin Pharmacol; 2000 Jul; 40(7):770-80. PubMed ID: 10883419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of oral [14C]cefcanel daloxate hydrochloride in healthy male subjects.
    Edwall B; Arvidsson A; Lake-Bakaar D; Lanbeck-Vallén K; Yisak W
    Drug Metab Dispos; 1993; 21(1):171-7. PubMed ID: 8095213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans.
    Kreis W; Gordon CS; DeJager R; Krakoff IH
    Cancer Res; 1975 Sep; 35(9):2453-60. PubMed ID: 1149046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects.
    Sadler BM; Chittick GE; Polk RE; Slain D; Kerkering TM; Studenberg SD; Lou Y; Moore KH; Woolley JL; Stein DS
    J Clin Pharmacol; 2001 Apr; 41(4):386-96. PubMed ID: 11304895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration.
    Callahan MM; Robertson RS; Arnaud MJ; Branfman AR; McComish MF; Yesair DW
    Drug Metab Dispos; 1982; 10(4):417-23. PubMed ID: 6126344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
    Blight AR; Henney HR
    Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.